Cargando…

Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease

The Coronavirus Disease 2019 (COVID-19) is caused by the betacoronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus that can mediate asymptomatic or fatal infections characterized by pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. Several studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peñaloza, Hernán F., Lee, Janet S., Ray, Prabir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412274/ https://www.ncbi.nlm.nih.gov/pubmed/34473802 http://dx.doi.org/10.1371/journal.ppat.1009850

Ejemplares similares

COVID-19 pandemic and gynaecological laparoscopic surgery: knowns and unknowns
por: Mallick, R, et al.
Publicado: (2020)

Lymphopenia: A useful predictor of COVID-19 disease severity and mortality
por: Toori, Kaleem Ullah, et al.
Publicado: (2021)

Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19
por: Shahridan Faiez, Tasnim, et al.
Publicado: (2022)

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
por: Tan, Li, et al.
Publicado: (2020)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

CD8+ T Cell Control of HIV—A Known Unknown
por: Davenport, Miles P., et al.
Publicado: (2010)

Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus
por: Cheng, Yangyang, et al.
Publicado: (2021)

Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
por: Tan, Li, et al.
Publicado: (2020)

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
por: Huang, Ian, et al.
Publicado: (2020)

Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
por: Martínez-Urbistondo, María, et al.
Publicado: (2021)

ACE2 and COVID-19 Susceptibility and Severity
por: Zheng, Ming
Publicado: (2022)

Neutrophil-mediated Thrombosis and NETosis in Behçet's Disease: a Hypothesis
por: Batu, Ezgi Deniz
Publicado: (2020)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
por: Huang, Glen, et al.
Publicado: (2020)

Post-Coronavirus Disease-2019 (COVID-19): Toward a Severe Multi-Level Health Crisis?
por: Ghanemi, Abdelaziz, et al.
Publicado: (2021)

Possible Mechanisms of Lymphopenia in Severe Tuberculosis
por: Li, Fei, et al.
Publicado: (2023)

An ocular lesion of unknown aetiology
por: Drosslerova, Marie, et al.
Publicado: (2021)

Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room
por: Assandri, Roberto, et al.
Publicado: (2020)

Microvascular Thrombosis as a Critical Factor in Severe COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2023)

Lymphopenia and autoimmune diseases
por: Schulze-Koops, Hendrik
Publicado: (2004)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes
por: Kruglikov, Ilja L., et al.
Publicado: (2021)

Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2020)

High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients
por: Pimentel, Gustavo D., et al.
Publicado: (2020)

Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia
por: Taban, E M, et al.
Publicado: (2021)

Corona Covid-19 virus and severe hypoxia in young patients without underlying disease: High prevalence rate with blood group A
por: Solhpour, Ali, et al.
Publicado: (2020)

Is lymphopenia different between SARS and COVID‐19 patients?
por: Yan, Shaomin, et al.
Publicado: (2021)

COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
por: Zhao, Qianwen, et al.
Publicado: (2020)

Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003)

Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

High prevalence of infections in non-COVID-19 patients admitted to the Emergency Department with severe lymphopenia
por: Baïsse, Arthur, et al.
Publicado: (2022)

The link between chronic periodontitis and COPD: a common role for the neutrophil?
por: Usher, Adam KH, et al.
Publicado: (2013)

Effect of COVID-19 on cardiorenal axis: known or unknown universe?
por: Armentano, G.M., et al.
Publicado: (2022)

Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?
por: Bari, Attia, et al.
Publicado: (2021)

Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
por: Lo Presti, Elena, et al.
Publicado: (2021)

Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
por: Zhang, Sifan, et al.
Publicado: (2021)

The function of myeloid-derived suppressor cells in COVID-19 lymphopenia
por: Li, Taosan, et al.
Publicado: (2022)

Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)?()
por: He, Lina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fr16fkbbv9uhje5s796uc4uqb3